Reply: outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

Liver Transpl. 2010 May;16(5):688; author reply 689-90. doi: 10.1002/lt.22041.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Graft Rejection / drug therapy*
  • Hepatitis C / surgery*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation*
  • Postoperative Complications / prevention & control*
  • Randomized Controlled Trials as Topic
  • Secondary Prevention
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Tacrolimus